Literature DB >> 23147904

Paediatric rheumatology: RCT of adalimumab supports anti-TNF therapy for juvenile-onset ankylosing spondylitis.

Emma Leah.   

Abstract

Entities:  

Year:  2012        PMID： 23147904     DOI： 10.1038/nrrheum.2012.202

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement.

Authors:  Gerd Horneff; Sigrid Fitter; Ivan Foeldvari; Kirsten Minden; Jasmin Kuemmerle-Deschner; Nicolay Tzaribacev; Angelika Thon; Michael Borte; Gerd Ganser; Rolf Trauzeddel; Hans-Iko Huppertz
Journal:  Arthritis Res Ther       Date:  2012-10-24       Impact factor: 5.156
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.